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Abstract
The vocal fold mucosa is a biomechanically unique tissue comprised of a densely cellular epithelium, superficial to an
extracellular matrix (ECM)-rich lamina propria. Such ECM-rich tissues are challenging to analyze using proteomic assays,
primarily due to extensive crosslinking and glycosylation of the majority of high Mr ECM proteins. In this study, we
implemented an LC-MS/MS-based strategy to characterize the rat vocal fold mucosa proteome. Our sample preparation
protocol successfully solubilized both proteins and certain high Mr glycoconjugates and resulted in the identification of
hundreds of mucosal proteins. A straightforward approach to the treatment of protein identifications attributed to single
peptide hits allowed the retention of potentially important low abundance identifications (validated by a cross-sample
match and de novo interpretation of relevant spectra) while still eliminating potentially spurious identifications (global
single peptide hits with no cross-sample match). The resulting vocal fold mucosa proteome was characterized by a wide
range of cellular and extracellular proteins spanning 12 functional categories.
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Introduction
The vocal fold (VF) mucosa is a complex multi-layered
biological system consisting of a squamous cell epithelium,
basement membrane and lamina propria (LP). Each mucosal
layer holds a distinct set of functions that are together responsible
for VF immune, transport and barrier capabilities, the ability to
absorb considerable impact stress, and favorable viscoelasticity for
self-sustained tissue oscillation and voice production [1–9]. The
epithelium and basement membrane represent the most superficial
layers of the VF mucosa and jointly provide a protective physical
barrier against mucosal insult [1,3]. Surface epithelial cells signal
professional immune cells in response to incident challenges from
the upper airway [7,8,10,11] and mediate water and ion transport
for the maintenance of VF surface hydration [4–6].
Deep to the basement membrane, the LP is populated by
sparsely distributed fibroblast cells housed in a biomechanically
favorable extracellular matrix (ECM) [2,9]. ECM fibrous proteins
(collagens and elastins) confer three-dimensional matrix organiza-
tion, strength and elasticity [2]; whereas interstitial glycans
(proteoglycans, glycoproteins and glycosaminoglycans) influence
matrix viscosity, hydration and volume [9]. These proteins and
glycans are functionally interdependent within the ECM, and
often operate in a synchronous and coordinated fashion. For
example, decorin modulates stress transmission along collagen
fibrils, and also influences fibril organization; fibromodulin binds
to collagen and regulates collagen synthesis; fibronectin facilitates
cell adhesion and upregulates collagen at wound sites; and versican
binds to hyaluronic acid, allows compression, and dissipates
impact stress [9,12–14]. These coordinated interactions under-
score the inherent complexity of both ECM and overall VF
mucosal function as well as the importance of investigating
complete functional protein-protein and protein-glycan groups
using system-wide methodologies.
While the importance of the VF mucosa (and its protein/glycan
constituents) to overall VF physiology and voice production is clear
[2,9], scientific understanding of its native biological structure and
function, and the manner in which it is altered under certain
physiological and disease states, remains limited. Historically, most
VF research has been driven by an experimental paradigm
focused on individual and small groups of genes/proteins, selected
based on their presumed structure and function, and generally
informed by work conducted in other mucosal systems. These
approaches have generated improved appreciation of specific
mucosal constituents, but hold notable limitation in contributing to
an overarching and unifying understanding of how these
individual players interact to form a functional biological and
biomechanical system. Microarrays and other mRNA detection
technologies have given insight into the transcriptome-wide
regulation of diseased VF mucosa [15]; however these assays do
not address important parameters such as alternately spliced
transcripts and post-translational modifications. Proteomic data-
sets transcend these limitations by capturing the operational
profiles of the majority of expressed proteins subsequent to
transcription and translation, and in doing so represent the entire
functional output of a given system. As such, proteomic
approaches promise to alter how the VF mucosa is conceptualized
and potentially open new avenues in the evaluation and treatment
of VF mucosal disease.
ECM-rich tissues such as the VF mucosa are challenging to
analyze using proteomic assays, primarily due to the extensive
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[16,17]. In this study, we implemented an LC-MS/MS-based
strategy to characterize the rat VF mucosa proteome. The rat is a
well-accepted model in VF biology [18–24] and has been
previously used in proteomic studies of the thyroarytenoid (TA)
muscle [25–27]. We successfully solubilized both proteins and high
Mr glycoconjugates from rat VF mucosa, and identified a
comprehensive library of proteins spanning twelve functional
categories.
Results
We first evaluated our ability to solubilize proteins and high Mr
glycoconjugates from rat VF mucosa samples. Fig. 1 illustrates
representative 1-DE separation and positive immunoblotting of rat
VF mucosa for the glycoprotein fibronectin and proteoglycan
fibromodulin, confirming successful extraction and retention of
these glycosylated ECM constituents. Fibronectin was detected at
an expected 220610
3 Mr (native fibronectin is comprised of two
220610
3 Mr subunits which are separated on reducing SDS-
PAGE) and appeared as a diffuse band suggesting varying degrees
of glycosylation. Fibromodulin was detected as two distinct bands
at 42 and 67610
3 Mr. Based on previous electrophoretic
characterization [28,29], the 42610
3 Mr band is consistent with
the non-glycosylated fibromodulin core protein and the 67610
3
Mr band is consistent with its N-linked oligosaccharide-substituted
form. We did not observe evidence for a keratan sulfate-substituted
form (typically detected as a series of diffuse bands between 70 and
110610
3 Mr) in these samples.
Next, we performed parallel LC-MS/MS runs on three
independent samples, following initial Mr-based sample fraction-
ation using 1-DE. Peptide and protein identifications were
compared across independent sample runs in an attempt to
salvage and validate potentially important low abundance
proteins, as follows. Cross-sample matching was performed with
special consideration of proteins identified by a single unique
peptide. Proteins identified by a single unique peptide in a given
sample (termed local single peptide hits) were categorized into two
subsets: Those with a corresponding protein match in another
sample (such a cross-sample match could have any number of
peptide hits), and those with no corresponding protein match in
another sample (termed global single peptide hits). Matching of protein
identifications across samples was then performed with all peptide
hits retained, with local single peptide hits removed, and with
global single peptide hits removed.
We initially identified a total of 756 unique peptides associated
with 340 proteins across all three samples, using a 1% estimated
false discovery rate (Fig. 2A–B). This analysis was marked by a
significant number of local single peptide hits (108 [46.9% of 230]
in sample 1; 98 [56.3% of 174] in sample 2; 119 [57.8% of 206] in
sample 3). Removing all local single peptide hits prior to matching
resulted in a 53.2% decrease in total proteins identified to 159,
whereas removing only global single peptide hits resulted in a
37.9% decrease in total proteins identified to 211 (Fig. 2B).
Further, as the removal of global single peptide hits only affected
protein identifications with no cross-sample matches, this strategy
yielded improved percentage agreement across samples, resulting
in 82.5% of identified proteins matched across at least two of three
samples (Fig. 2B).
Detailed analysis of local single peptide hits (Fig. 3A–B) revealed
that 30.6–46.3% of these protein identifications were global single
peptide hits, confirming that the majority of protein identifications
associated with a single unique peptide had a positive cross-sample
match. Further, 19.4-39.8% of these identifications were matched
across all three samples (Fig. 3B). A large number of cross-sample
matches were to other single unique peptides; however, some
matches had as many as seven unique peptides (Fig. 3A). To
complement this analysis, we implemented secondary validation of
MS/MS spectra associated with local single peptide hits using de
novo peptide sequencing followed by MS-driven BLAST searching
[30]. Thirty-two database hits failed this validation step and were
therefore considered false positives.
Table S1 contains functional classification data for proteins
identified by LC-MS/MS following the removal of global single
peptide hits and local single peptide hits derived from spectra that
failed de novo sequencing-based validation. Proteins were classified
using annotation and categorization data in the UniProtKB/
Swiss-Prot database [31]. A wide range of cellular and
extracellular proteins were identified, spanning 12 functional
categories: Circulatory system, blood proteins; cytoskeletal pro-
teins (microfilament, intermediate filament, microtubules) includ-
ing nuclear envelope and epithelial keratins; DNA binding
proteins; defense, stress and immune response proteins; ECM
proteins; membrane (cell, nuclear, mitochondrial) proteins;
metabolism and energy proteins; cell motility, contractile/thick
filament proteins; protein fate (maturation, modification, traffick-
ing, degradation); signaling proteins; protein translation/synthesis;
and miscellaneous proteins.
We selected four representative VF mucosa proteins from Table
S1 for additional immunohistochemical validation. The ECM
protein collagen type I and glycoprotein fibronectin were detected
Figure 1. 1-DE of rat vocal fold mucosa demonstrates high
sample complexity and ECM glycoprotein/proteoglycan reten-
tion. (A) Representative sample separated by 10% SDS-PAGE and silver
stained. (B) Representative immunoblots for fibronectin (Fn) and
fibromodulin (Fmod). Fibronectin was detected at 220610
3 Mr and
appeared variably glycosylated. Fibromodulin was detected as two
distinct bands at 42610
3 Mr (non-glycosylated core protein) and
67610
3 Mr (N-linked oligosaccharide substituted form).
doi:10.1371/journal.pone.0017754.g001
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PLoS ONE | www.plosone.org 2 March 2011 | Volume 6 | Issue 3 | e17754Figure 2. Comparison of peptide and protein identifications generated from LC-MS/MS runs representing three independent vocal
fold mucosa samples. (A) Distribution of number of unique peptides per protein identification across samples, and overlap in unique peptide
identifications across samples. (B) Number of protein identifications and overlap across samples, with varying treatment of proteins identified bya
single unique peptide identification (all peptide hits retained, local single peptide hits removed, global single peptide hits removed). Due to
rounding, not all percentages total to 100.0%.
doi:10.1371/journal.pone.0017754.g002
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LP (Fig. 4A–B). The intermediate filament protein vimentin was
detected in the cytosol of the majority of cells in the LP (Fig. 4C);
whereas the intermediate filament protein keratin Ka10 was
exclusively localized to the epithelium (Fig. 4D).
Discussion
The individual protein species and general categories identified
in our dataset represent a wide array of structural and functional
agents in the VF mucosa, many of which are of known importance
to performance of this tissue, and therefore valuable markers for
future quantitative proteomic studies. In addition to ubiquitous
proteins that underpin fundamental cellular processes such as
energy metabolism, transcription and translation, protein modifi-
cation and transport, we identified a large complement of
epithelial intermediate filament keratins, several ECM proteins
and glycoconjugates, and a number of skeletal muscle thick
filament proteins. Detection of these thick filament proteins infers
muscle fiber contamination of our VF mucosa samples, despite
careful microdissection and no evidence of TA muscle disturbance
at the macro level. Complete elimination of all invasive muscle
fibers may require preparation of frozen tissue sections followed by
laser capture microdissection. This approach, which has been
Figure 3. Analysis of proteins identified by a single unique peptide in LC-MS/MS runs representing three independent vocal fold
mucosa samples. (A) Distribution of protein identifications with a single unique peptide hit in one or more samples (local single peptide hits). Data
are further subcategorized into proteins with no cross-sample match (global single peptide hits) and proteins with a cross-sample match. (B) Venn
diagrams illustrating overlap in local single peptide hits (i.e., number of cross-sample matches) for each sample. Non-overlapping regions in each
Venn diagram represent global single peptide hits. Due to rounding, not all percentages total to 100.0%.
doi:10.1371/journal.pone.0017754.g003
Figure 4. Representative images showing immunohistochem-
ical validation of four vocal fold mucosa proteins identified
using LC-MS/MS. Frozen sections were stained with antibodies anti-
collagen type I (labeled red in A), anti-fibronectin (labeled red in B), anti-
vimentin (labeled red in C), anti-keratin Ka10 (labeled red in D), and
nuclear dye DAPI (labeled blue in A–D). Scale bar =40 mm.
doi:10.1371/journal.pone.0017754.g004
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accurate separation of the VF epithelium and LP, in addition to
the investigation of regional areas of interest within the LP, such as
the maculae flavae.
The tightly regulated protein/glycan constituency of the LP
ECM is critical to the biomechanical capacity of the VF mucosa
for self-sustained oscillation. In this study, we successfully extracted
and identified a number of procollagen/collagen isoforms, in
addition to the proteoglycans decorin and fibromodulin, and the
glycoproteins fibronectin, fibrillin and laminin. It is important to
note that a number of known LP ECM constituents (such as the
fibrous proteins collagen type III and elastin, and glycosamino-
glycan hyaluronic acid) were not detected in our LC-MS/MS
runs. As noted, ECM is generally a challenging target for
proteomic analysis due to the high Mr, poor solubility and poor
digestability of the majority of ECM proteins, many of which are
extensively crosslinked and/or glycosylated [16,17]. High Mr
glycans and glycoconjugates are also known to impair isoelectric
focusing during 2-DE [34–36]. Work in other ECM-rich tissues
such as cartilage has shown improved protein resolution on 2-DE
following depletion of high Mr glycans using centrifugal filtration
[34,37,38], anion exchange chromatography [35] and cetylpyr-
idinium chloride precipitation [36,39]. Also, trypsin digestion of
ECM prior to LC-MS/MS appears to be significantly enhanced
by ultrasonication and incorporation of an acid-labile surfactant
treatment [16]. Analysis of ECM glycans and glycoconjugates may
be best achieved by initial isolation from the larger proteome using
antibody or lectin affinity chromatography, and/or metabolic
labeling [40]. Finally, compared to collision induced dissociation,
electron transfer dissociation-based MS may be favorable for
determining glycosylation site and glycan size, due its tendency to
preferentially fragment the protein backbone while leaving glycan
side chains largely intact [41].
The validation of borderline protein identifications using cross-
sample matching of local single peptide hits in our dataset
illustrates the value of performing MS/MS on multiple indepen-
dent samples, and is a computationally straightforward approach
to enhancing the identification of low abundance proteins.
Further, secondary validation using de novo interpretation of
relevant spectra provides additional protection against unwanted
false positives. Conservative approaches to database-driven
proteomics typically define a positive protein identification as
characterized by two or more unique peptides [42–44]. Although
this approach stringently guards against false positives, it also
removes a large number of potentially valuable protein identifi-
cations (53% of total protein identifications in our dataset). The
ideal management of single peptide hits involves maximizing true
positive protein identifications while maintaining a strict false
discovery rate. A recent body of literature in this area suggests that
improved proteome coverage can be achieved by analyzing
samples multiple times, using multiple MS instruments, and using
multiple search algorithms [42]; and that true positive protein
identifications associated with single peptide hits can be salvaged
via de novo sequencing (as used in this study) [45], modified decoy
database searching [46], and/or the application of various
modeling approaches [43]. Interestingly, it appears that automatic
elimination of all protein identifications based on single peptide
hits results in the disproportionate depletion of positive identifi-
cations in target and decoy databases, which has driven a recent
argument that protein identifications should be subject to
estimated false-positive rates, similar to the current standard
commonly employed for peptides [44]. The approach to
managing single peptide hits employed in this study is attractive
in that it maintains a stringent estimated false-positive rate at the
peptide level, while salvaging a significant proportion of true
positive protein identifications based on the assurance of cross-
sample validation and de novo peptide sequencing.
Materials and Methods
This study was performed in accordance with the PHS Policy
on Humane Care and Use of Laboratory Animals, the NIH Guide
for the Care and Use of Laboratory Animals, and the Animal Welfare Act
(7 U.S.C. et seq.); the animal use protocol was approved by the
Institutional Animal Care and Use Committee of the University of
Wisconsin-Madison (approval M1742).
Experimental animals
Three experimentally naı ¨ve four-month-old male Sprague
Dawley rats were used for immunoblotting and proteomic assays.
Each animal was euthanized via CO2 asphyxiation. The larynx
was harvested en bloc, separated along the midline, and the VF
mucosa (epithelium and entire LP) were undermined and dissected
from the TA muscle. All dissection procedures were performed
under a stereo dissection microscope using microsurgical instru-
ments and 27-G needles. Each larynx was inspected to confirm TA
muscle integrity following microdissection and each sample was
processed for 1-D SDS-PAGE followed by either immunoblotting
or band excision with subsequent LC-MS/MS. The time duration
from euthanasia to completion of dissection was approximately
10 min in all cases.
Sample preparation
VF mucosa samples (left and right samples from a single animal
were combined) were placed in 25 mL osmotic lysis buffer (0.3%
SDS, 10 mM Tris; pH 7.4) containing 10% nuclease (500 mg/mL
RNase, 1 mg/mL DNase, 50 mM MgCl2, 100 mM Tris; pH 7.0)
and 1% protease inhibitor (20 mM AEBSF, 1 mg/mL leupeptin,
360 mg/mL E-64, 500 mM EDTA, 560 mg/mL benzamidine)
solutions. Tissue homogenization was performed on ice using an
ultrasonic homogenizer (300V/T; Biologics, Manassas, VA) for
6 min at 40% power with a micro tip. After the addition of 25 mL
boiling buffer (5% SDS, 10% glycerol, 60 mM Tris; pH 6.8), the
samples were placed in a boiling water bath for 30 min to facilitate
dissolution, cooled on ice, and then centrifuged to pellet solids.
After removing an aliquot for total protein quantitation, the
samples were microdialyzed at 4uC overnight using 5 mM Tris
pH 6.8 and a 6–8610
3 Mr cut-off membrane filter. Next, the
samples were lyophilized and reconstituted to 1 mg/mLi na1 : 1
ratio of boiling buffer to urea buffer (9.5 M urea, 2% w/v
IGEPAL CA-630, 5% beta-mercaptoethanol) before gel loading.
Total protein quantitation was performed spectrophotometri-
cally using the bicinchoninic acid method [47] and kit produced
by Pierce Biotech (Rockford, IL). BSA was employed as a standard
and absorbance at 562 nm was measured using the Smart Spec
3000 spectrophotometer (Bio-Rad, Hercules, CA). Samples were
analyzed in duplicate and data were averaged. Mean final
measurements of total protein were ,150 mg for all samples.
Electrophoresis
1-D SDS-PAGE was performed using a 0.75-mm thick 10%
acrylamide slab gel. Electrophoresis was performed for approxi-
mately 4 h using 15 mA/gel. Total protein load was 5 mg for gels
intended for silver staining [48] and 25 mg for a series of replicate
gels intended for CBB staining, PVDF membrane transfer for
immunoblotting, or band excision for LC-MS/MS. Six proteins
(Sigma, St. Louis, MO) were employed as Mr standards: Myosin
Proteome Coverage in Rat Vocal Fold Mucosa
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3), carbonic anhydrase (29610
3) and lysozyme (14610
3).
Immunoblotting
1-D SDS-PAGE separated samples were placed in transfer
buffer (12.5 mM Tris pH 8.8, 96 mM glycine, 20% methanol) and
electrotransferred to PVDF membranes overnight using 100 mA/
gel. Non-specific sites were blocked using 5% nonfat milk in
Tween-20 TBS (TTBS) for 2 h, and then blots were washed in
TTBS. Each blot was incubated with the primary antibody diluted
in 2% nonfat milk in TTBS overnight, followed by the secondary
antibody diluted in TTBS for 2 h. Blots were washed three times
for 10 min in TTBS following each incubation. Following the final
wash, blots were treated with ECL and exposed to x-ray film.
The primary antibodies used for immunoblotting were
polyclonal rabbit anti- fibronectin (AB1954, 1:4000; Millipore,
Billerica, MA) and polyclonal rabbit anti-fibromodulin (sc-33772,
1:200; Santa Cruz Biotech, Santa Cruz, CA). The secondary
antibody used was HRP-conjugated anti-rabbit IgG (NA934,
1:2000; GE Healthcare, Piscataway, NJ).
LC-MS/MS
1-D gel lanes, representing 10-250610
3 Mr, were cut into 12
equally sized 1 cm bands. Bands were destained twice using
200 mL 100 mM NH4HCO3/50% methanol for 5 min and then
dehydrated using 200 mL2 5m MN H 4HCO3/30% acetonitrile
for 20 min followed by 100% acetonitrile for 1–2 min. Next,
samples were dried for 3 min in a speed-vac concentrator.
Reduction was performed using 50 mL2 5 m MN H 4HCO3/
25 mM dithiothreitol at 56uC for 20 min. Alkylation was
performed using 50 mL2 5m MN H 4HCO3/55 mM iodoaceta-
mide for 20 min in the dark. Samples were washed, dehydrated
and dried as described above and then digested using 60 ng
modified trypsin (Roche, Indianapolis, IN) in 15 mL2 5 m M
NH4HCO3 at 32uC overnight. Peptide extracts were reduced in
volume to ,10 mL in a speed-vac concentrator.
LC-MS/MS analysis was performed on a Micromass hybrid Q-
TOF mass spectrometer with a nanoelectrospray source (Waters
Corp, Milford, MA). Capillary voltage was set at 1.8 kV and cone
voltage 32 V; collision energy was set according to mass and
charge of the ion, from 14 eV to 50 eV. Chromatography was
performed on a LC Packings HPLC with a C18 PepMap column
(Dionex, Sunnyvale, CA) using a linear acetonitrile gradient and
200 nL/min flow rate.
Spectral peaks were extracted from raw data files using
ProteinLynx 4.0 (Waters Corp) and default parameters. Peak lists
(in PKL format) from the analysis of all 12 digested gel bands
representing a single sample were concatenated using the Perl
script merge.pl (http://www.matrixscience.com) and exported in
MGF format. Peptide searches were performed using Mascot 2.0
(Matrix Science, London, UK) [49] running on a local server, with
the following search parameters: tryptic digestion; one allowable
missed cleavage; 0.2 Da tolerance for both precursor and fragment
ions; 2+ and 3+ ions; fixed cysteine carbamidomethylation;
variable methionine oxidation and NQ deamidation. Concatenat-
ed forward and reverse sequences from the NCBI Refseq rat
protein database (updated 10.18.2006; 36,496 forward sequences)
[50] were used for searching. This database was selected as it was
rat specific, non-redundant and allowed decoy searching for the
calculation of estimated false-positive rates. The threshold for
positive protein identification was set using a 1% estimated false-
positive rate, which corresponded to a probability based Mowse
score of 32. Estimated false-positive rates and cut-off thresholds
were calculated using previously reported algorithms [51] and
scripts written in Mathematica 5.2 (Wolfram Research, Cham-
paign, IL).
MS/MS spectra associated with local single peptide hits were
subjected to additional validation using de novo peptide sequencing
and MS-based BLAST searching, as follows. Relevant spectra
were parsed from the concatenated MGF format data file and
subjected to de novo analysis using PepNovo+3.1 beta, a previously
reported probabilistic network-based sequencing algorithm [30].
Input parameters were identical to those used for Mascot database
searching. Resulting candidate peptide sequences were submitted
to a publically available MS-BLAST server (http://genetics.bwh.
harvard.edu/msblast/) [52] using the nr95_clean database and
default search parameters.
Immunohistochemistry
Three additional age- and sex-matched Sprague Dawley rats
werereserved for immunohistochemical validation of select proteins
identified using LC-MS/MS. Laryngeal specimens were harvested
and immediately embedded in optimum cutting temperature
compound (Tissue-Tek; Sakura, Tokyo, Japan), frozenwithacetone
anddryice,and storedat280uC.Thelaryngesweresectionedatan
interval of 8 mm in the coronal plane using a cryostat (CM-3050 S;
Leica, Wetzlar, Germany). Two adjacent coronal sections,
containing the midmembranous vocal fold mucosa immediately
anterior to the laryngeal alar cartilage, were selected from each
animal for each marker of interest. The midmembranous mucosa
was selected as it is an important tissue region for vocal fold
oscillation; the laryngeal alar cartilage was selectedas an anatomical
landmark to ensure that all immunostained sections reflected a
consistent anterior-posterior level in the coronal plane.
Frozen sections were fixed in 4% paraformaldehyde, washed with
phosphate-buffered saline, and incubated with Block-Ace (AbD
Serotech, Raleigh, NC) and 5% goat serum (Sigma) for 30 min to
block nonspecific binding. Next, sections were incubated with
primary antibody rabbit anti-collagen type I (ab34710, 1:100;
Abcam, Cambridge, MA), rabbit anti-fibronectin (LSL-LB-1027,
1:300; Cosmo Bio, Tokyo, Japan), mouse anti-vimentin (M7020,
1:200; Dako, Carpinteria, CA) or mouse anti-keratin Ka10
(MAB1605, 1:200; Millipore) for 90 min, followed by secondary
antibody rhodamine red conjugated goat anti-mouse or anti-rabbit
IgG (1:200; Jackson ImmunoResearch, West Grove, PA) for 60 min,
with thorough wash steps between each incubation. Finally, slides
were covered with antifade mounting medium with DAPI (Vecta-
shield; Vector Labs, Burlingame, CA) and cover-slipped. Control
sections stained with an isotype control or without the primary or
secondary antibody showed no immunoreactivity (data not shown).
Immunostained images were captured using a fluorescent
microscope (E-600; Nikon, Melville, NY) equipped with a digital
microscopy camera (DP-71; Olympus, Center Valley, PA) at 100X
magnification. Consistent exposure parameters were used for each
marker to allow the direct comparison of fluorescent intensity
across experimental conditions. Representative images were
selected for presentation.
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